Free tool
XLV and RAGHX: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between XLV and RAGHX
49% of their top holdings overlap by weight, with 11 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that XLV holds far more positions (65 vs 24), so it is broader beyond the top names.
| Holding | % of XLV | % of RAGHX |
|---|---|---|
| Eli Lilly & Co | 16.51% | 14.84% |
| AbbVie Inc | 7.74% | 5.52% |
| UnitedHealth Group Inc | 6.57% | 4.65% |
| Merck & Co Inc | 5.52% | 5.06% |
| Amgen Inc | 3.40% | 3.85% |
| Thermo Fisher Scientific Inc | 3.24% | 3.65% |
| Intuitive Surgical Inc | 2.45% | 3.89% |
| Vertex Pharmaceuticals Inc | 2.19% | 5.32% |
| Danaher Corp | 2.09% | 3.37% |
| McKesson Corp | 1.58% | 4.57% |
| Regeneron Pharmaceuticals Inc | 1.08% | 2.90% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized